Back to Results
First PageMeta Content
Sexually transmitted diseases and infections / Pharmacology / Dendrimer / Antiseptics / Microbicides / Microbicides for sexually transmitted diseases / Docetaxel / Condom / Pharmaceutical industry / Chemistry / Medicine / Health


STARPHARMA HOLDINGS LIMITED ASX: SPL; OTCQX: SPHRY Company Overview – MarchStarpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is an innovative Australian biotechnology company with a
Add to Reading List

Document Date: 2015-03-10 23:04:17

Open Document

File Size: 182,99 KB

Share Result on Facebook

City

Melbourne / /

Company

Ansell Limited / Lilly / Share Price AUD / 3M / AstraZeneca / Okamoto Industries Inc. / STARPHARMA HOLDINGS LIMITED / Nigel Baade CFO & Company / /

Country

New Zealand / Japan / United States / Australia / China / /

Currency

AUD / USD / /

/

Event

FDA Phase / Funding / Business Partnership / /

IndustryTerm

biotechnology / cancer therapies / number pharmaceutical / pharmaceutical / dendrimer products / pharmaceutical and agrochemical uses / stand-alone product / pharmaceutical products / anti-cancer product / /

MarketIndex

ASX / /

MedicalCondition

colorectal cancer / breast / lung and prostate cancer / Bacterial Vaginosis / common vaginal infection / cancer / important cancer / tumour / recurrent bacterial vaginosis / sexually transmitted infections / /

MedicalTreatment

chemotherapies / dendrimer / cancer therapies / Dendrimers / /

Organization

US Food and Drug Administration / FDA / /

Person

Rebecca Wilson / Jackie Fairley / /

/

Position

Chief Executive Officer / Secretary / market leader / /

Product

LifeStyles / VivaGel® / DEP™ / DEP / VivaGel / /

Technology

agreement applying DEP™ technology / drug-delivery / biotechnology / pharmacokinetics / Drug Delivery / /

URL

www.starpharma.com / /

SocialTag